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Both Caspase-3 and Caspase-9 play critical roles in the execution of mitochondria-mediated apoptosis. Caspase-9 binds to Apaf-1 in the
presence of cytochrome c and dATP/ATP, and is activated by self-cleavage. Caspase-3 is activated by cleavage of caspase-8 and caspase-9. Over
hundred direct caspase-3 substrates are identified whereas only few direct caspase-9 substrates are known. Here, we demonstrate that Ring1B, a
component of polycomb protein complex that plays important roles in modulating chromatin structures, is a direct substrate of active caspase-3
and caspase-9 both in vitro and in vivo. The specific cleavage sites for caspase-3 and caspase-9 were mapped to Asp175 and Asp208, respectively.
Importantly, cleavage of Ring1B by active caspases-3 and caspase-9 triggers the redistribution of Ring1B, from exclusive nuclear localization to
even distribution throughout the entire cell. The transcriptional repression activity of Ring1B was also disrupted by caspase cleavage. Our data
suggest that caspases-3 and caspase-9 play novel roles in transcription by regulating polycomb protein function through direct cleaving of Ring1B.
© 2007 Elsevier B.V. All rights reserved.Keywords: Ring1B; Polycomb group protein; Caspase-3; Caspase-9; Nuclear localization; Transcriptional repression1. Introduction
Apoptosis is important in governing development and cell
homeostasis in multi-cellular organisms, and is tightly regulated
by cysteine-dependent aspartate-specific proteases (caspases)
[1]. Caspases contain an N-terminal prodomain, a large subunit
in the middle, and a small subunit at the C-terminal. They can be
divided into upstream initiator caspases such as caspases-2, -8,
-9 and downstream effector caspases such as caspases-3, -6 and
-7 [2]. Initiator caspases contain a long N-terminal prodomain
for recruitment of factors for activation, while effector caspases
have a short prodomain, so they require cleavage by activated
initiator caspases. Over 200 caspase substrates were discovered
[3] and they can be classified into several functional classes,
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cleavage by caspases can functionally inactivate or activate a
protein depends.
Pro-caspase-3 can be activated by Calpain, caspase-8 and
caspase-9 [4]. Activated caspase-3 can specifically cleave its
substrates at DEXD motif [5]. Depletion of caspase-3 in cells
fails to show characteristic DNA fragmentation, chromatin
marginization and nuclear collapse. It is because ICAD
(inhibitor of CAD) was cleaved by active caspase-3, so, CAD
(caspase-activated DNase) is no longer bound to ICAD and free
CAD enters the nucleus and acts upon chromatin [6]. Cleavage
of gelsolin and PAK2 by active caspase-3 promotes rounding-up
of cells and formation of apoptotic bodies, respectively [7,8].
Overall, caspase-3 plays important roles inmorphologic changes
and cell demise during apoptosis.
In the presence of cytochrome c and ATP/dATP, caspase-9
binds to adaptor protein Apaf-1 through the CARD domain,
leading to its conformational change and auto-activation [9,10].
Activated caspase-9 can specifically cleave its substrates at
(L/V)EXD motif [5]. Being an initiator caspase, activated
caspase-9 can cleave and activate downstream effector caspase-
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caspase-3 during apoptosis but also cleaves non-caspase
substrates [11,12]. Vimentin is one of the major components
of intermediate filaments that can be cleaved by caspase-9.
Caspase-9 cleavage product of vimentin is detected in the
interdigital regions during embryonic nervous system develop-
ment, suggesting that caspase-9 could play a role in dismantling
cytoskeleton structure during apoptosis [11]. Cleavage of
amyloid precursor protein by caspase -9 at the C-terminus
generates a novel proapoptotic peptide, whichmay be associated
with neuronal death in the Alzheimer's disease [12]. Moreover,
caspases have been shown to be important in non-apoptotic
processes, such as cell proliferation and differentiation [13].
Although the role of caspases-9 in the mitochondria-mediated
apoptotic pathway has been well established in vivo, its potential
role in regulating other biological processes remains obscure.
Polycomb Group (PcG) genes were originally identified for
their ability to maintain transcriptional repression of homeotic
genes during Drosophila development [14,15]. Mammalian
genes that are structurally and functionally related toDrosophila
PcG have been identified. PcG gene products form large protein
complexes by members within the PcG family and other
proteins. Ring1A/B proteins were originally identified as one of
the components of PcG protein complexes by virtue of their
interaction with other PcG proteins [16–22]. They are highly
homologous to each other and contain a cysteine-rich ring finger
domain at the N-terminus, an important characteristic of
ubiquitin and Sumo E3 ligases. Indeed, Ring1B was shown to
possess an E3 ligase activity [23]. Although there is no direct
evidence to show that PcG proteins bind to DNA directly, PcG
proteins behave as strong transcriptional repressors when they
are recruited to promoters by altering chromatin to inactive
structures and silencing gene expression [24–26]. Ring1A was
shown to be a potential transcriptional repressor [16]; however,
little is known about the underlying mechanism of the Ring1A-
mediated transcriptional repression except that the central region
of Ring1A is required for transcriptional repression. At least two
biochemically and functionally complexes were assembled by
PcG proteins. The initiation complex, Polycomb repressive
complex (PRC2) and the maintenance complex (PRC1) are
involved in developmentally regulated and tissue-specific
transcriptional silencing of Hox genes in flies and mammals
[27,28]. Ring1B belongs to PRC1 together with Bmi1, EDR1
and CBX4 [29,30]. Recently, Ring1B was found to be
transiently enriched on inactive X-chromosome during early
development [31]. It is part of the E3 ubiquitin ligase complex
responsible to maintain levels of histone H2A ubiquitination and
transcriptional repression [29]. Whereas expression of Ring1A
mRNA was restricted to the developing central nerve system,
Ring1B mRNAs were detected ubiquitously during embryonic
development [32]. Ring1B deficiency leads to gastrulation arrest
and cell cycle inhibition, suggesting that Ring1B plays a critical
role in early mouse development [33].
Here, we found that Ring1B is a direct substrate of active
caspase-3 and caspase-9 both in vitro and in vivo. The specific
cleavage sites for caspase-3 and caspase-9weremapped toAsp175
and Asp208, respectively. Intriguingly, cleavage of Ring1B bycaspases-3 and -9 disrupts Ring1B nuclear localization and
attenuates its transcriptional repressor activity. Our data suggest
that caspases-3 and caspase-9 play a previously unrecognized role
in regulating polycomb protein-mediated gene silencing by
abrogating its transcriptional repression by proteolytic cleavage
upon apoptosis induction.2. Materials and methods
2.1. Cell lines and drug treatment
Human embryonic kidney cell-HEK293T, Cercopithecus aethiops kidney
cell-COS-7 and human epithelial cell-HeLa were grown in Dulbecco's modified
minimal essential medium supplemented with 10% heat-inactivated fetal calf
serum and 2 mM glutamine, 100 U/ml of penicillin and 100 mg/ml of
streptomycin in a humidified incubator with 5% (v/v) carbon dioxide, 37 °C
atmosphere. For inhibition experiments, the cellswere pre-incubatedwith z-VAD-
fmk, z-DEVD-fmk, z-LEHD-fmk (Calbiochem, USA) for 30 min and sub-
sequently treated with apoptotic stimuli Staurosporine (STS) (Sigma USA).
2.2. Plasmids and antibodies
Ring1B cDNAwas cloned from SH-SY5Y cell cDNA by PCR. Restriction
sites HindIII and XhoI were introduced at 5′ and 3′ end, respectively. The
fragments were then subcloned into Flag N-terminal epitope tagged mammalian
expression vector pXJ40 digested with HindIII/XhoI. All the Ring1B truncated
forms were generated by PCR using similar strategy. For GFP-tagged protein,
the cDNA fragments were released from pXJ40 vector with HindIII/XhoI and
subcloned into pEGFP-C3 (Clontech) cleaved by HindIII/SalI. All constructs
were confirmed by DNA sequencing. To generate Ring1B polyclonal antibody,
full-length Ring1B was cloned into pGEX-4T1 vector and GST-Ring1B fusion
proteins were isolated according to protocols described by Molecular Cloning
(Cold Spring Harbour). GST-Ring1B was injected into rabbit for polyclonal
antibody production. Anti-flag M2-agarose affinity gel, mouse anti-β-actin and
mouse anti-flag anti-bodies were purchased from Sigma (USA). Rabbit anti-
GFP anti-bodies were purchased from Molecular Probe (USA). Mouse anti-
Ring1B monoclonal antibodies were kindly provided by Dr. Haruhiko Koseki
(Chiba University, Chiba, Japan). Anti-cleaved-caspase-9 and anti-caspase-3
antibodies were purchased from Cell Signalling Technology (USA).
2.3. Transfection, immuno-precipitation and Western blot
Transfection of 293T, HeLa and COS-7 cells was performed by using
calcium or Lipofectamine Transfection Reagent (Invitrogen, USA) according to
the manufacturer's instruction. 36 h after transfection, cells were lysed with
300 ml cold lysis buffer [50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM
EDTA, 1% Triton X-100 with Cocktail protease inhibitors (Complete without
EDTA, Roche Diagnostics) and was scrapped into 1.5 ml Eppendoff tube.
Lysates were cleaned by centrifugation at 13,000×g for 30 min. For
immunoprecipitation, cell lysates were diluted in 600 ml lysis buffer, 10 ml of
50% Anti-Flag M2-agarose affinity gel (Sigma) was added. The lysates and the
beads were incubated at 4 °C for 3 h. Beads were precipitated by centrifugation
at 2000×g for 5 min and washed with lysis buffer for 3 times. For Western blot,
the precipitates were subjected to SDS-PAGE and were transferred onto
nitrocellular membrane (Hybond). The membranes were then immunobloted by
using appropriate antibodies. The specific protein bands were visualized by
SuperSignal West Pico Luminol (PIERCE, Rockford, IL) and exposed on
Hyperfilm (Amersham).
2.4. TNT and caspases cleavage assay
Proteins were labeled with T7 polymerase-coupled TNT rabbit reticulocyte
lysate system (Promega, USA) in the presence of [35S]methionine according to
the manufacturer's instruction. The labeled proteins were incubated with active
caspases (BD Pharmingen) in the caspase reaction buffer (50 mM HEPES pH
Fig. 1. Ring1B is a potential substrate of caspase-3 and caspase-9. (A) Schematic
representation showing the potential cleavage sites of Ring1B. (B) Ring1B
protein can be cleaved by active caspases- 3 and -9. [35S]-Methionine labeled
Ring1B protein was incubated with 1 unit of active caspase-2, -3, -6, -7, -8 and
-9 for 1 h. The reaction mixture was separated by SDS-PAGE gel. The
precursors and cleaved products were visualized by autoradiography.
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37 °C for 1 h (1 unit of active caspase=20 μM substrate cleaved per hour). The
reaction mixture were then separated by 15% SDS-PAGE gel and dried by Gel-
Dryer with vacuum at 80 °C for 1 h. The cleaved bands were visualized by
autoradiography.
2.5. Caspase-3 cleavage assay
1μg of Ring1BDNAwas transfected intoHeLa cells using calcium. 36 h after
transfection, cells were lysed with 300 ml cold lysis buffer and immunopreci-
pitated was done by using anti-flag-M2-agarose affinity gel (Sigma) as described
above. Beads were washed three times and were re-suspended into Caspase
reaction buffer. The beads were incubated with active caspase-3 in caspase
reaction buffer at 37 °C for 30 min. The reaction mixtures were separated by 12%
SDS-PAGE gel and were transferred onto nitrocellular membrane (Hybond). The
membranes were immunoblotted with anti-Ring1B anti-bodies.
2.6. Confocal microscopy
pEGFP-C3 vector alone and GFP-tagged Ring1B and its mutants were
transfected to COS-7 cells grown on coverslips. 24 h after transfection, cells
were fixed with 4% paraformaldehyde for 15 min in room temperature and
permeabilized by 0.1% tritron X-100 for 20 min. Cells were treated with 10 μM
of RNase for 20 min and stained with 1 μg/ml propedium iodide (Sigma) for
15 min. The coverslips were mounted on glass slides and cells were observed
under confocal microscope.
2.7. Transcriptional repression assay
To construct GAL-4-Ring1B proteins and its mutants, the cDNA fragments
were generated by PCR. Restriction sites NheI and NotI were introduced at 5′
and 3′ end, respectively. The fragments were digested by NheI and NotI and
were subcloned into pcDNA-GAL-4 vector. HeLa cells were transiently co-
transfected with 0.5 μg of GAL4-TK reporter construct and 3 μg of GAL4-
Ring1B deletion mutants. Luciferase activity was measured at 36 h post-
transfection. Fold repression was calculated by comparing with the reading of
reporter construct in five independent experiments.3. Results
3.1. Ring1B is a direct substrate of caspase-3 and -9 in vitro
In a search for novel proteins contain consensus caspase-3
and caspase-9 cleavage site, we observed that Ring1B protein
contains one potential caspase-3 and one potential caspase-9
cleavage sites at position 175 and 208, respectively (Fig. 1A).
According to Thorberry et al. [5], the amino acid at position
205–208, LELD, in Ring1B are predicted to be cleaved by
active caspase-6, -8 and -9 whereas position 172–175, DNGD,
is predicted to be cleaved by active caspase-2, -3 and -7. To test
whether Ring1B is indeed a substrate for caspases, [35S]-labeled
Ring1B proteins were incubated with 1 unit of active caspases-
2, -3, -6, -7, -8 and -9 (BD Pharmingen, USA). We observed
specific cleavage of Ring 1B by caspases-3 and -9 (Fig. 1B) but
not by other active caspases. While cleavage of Ring1B by
caspase-3 generated one distinct cleavage product around
18 kDa, cleavage of Ring1B by caspase-9 generated two
cleavage products around 15 kDa and 22 kDa. Our results
suggest that Ring1B can be cleaved by active caspase-3 and -9
in vitro and that, according to the size of the cleavage products,
the cleavage sites are aa 175 for the caspase-3 cleavage site and
aa 208 for the caspase-9.To confirm caspase-9 dependent cleavage, [35S]-labeled
Ring1B proteins were incubated with increasing amounts of
active caspase-9 in vitro. Ring1B proteins were cleaved into two
small fragments with the size of approximately 15 kDa and
22 kDa. The amount of cleaved products is increased when the
amount of active enzyme is increased (Fig. 2A). To determine
whether LELD208 is the caspase-9 recognition site, [35S]-labeled
Ring1B proteins with a single amino acid substitution at position
172 (Ring1BD172A), 175 (Ring1BD175A) and 208 (Ring1BD208A)
were generated and subjected to caspase-9 cleavage. As shown in
Fig. 2B, in the presence of active caspase-9, both Ring1BD172A
and Ring1BD175A proteins were cleaved into two fragments,
similar to those of wild type Ring1B. However, the Ring1BD208A
protein was completely resistant to caspase-9 cleavage. These
data suggest that the LELD208 is the caspase-9 recognition and
cleavage site, and that the 22 kDa and 15 kDa Ring1B proteolytic
products correspond to the aa 1–208 and 209–336, respectively.
We then tested whether Ring1B can be directly cleaved by
caspase-3. Flag-tagged Ring1B was transfected into 293T cells,
and was immuno-precipitated using anti-flag antibody, followed
by incubation with recombinant active caspase-3 (BD Pharmin-
gen) in vitro. The precursor and cleaved products of Ring1B
were identified by rabbit polyclonal anti-bodies against full-
length Ring1B. As shown in Fig. 2C, in the presence of
increasing amounts of active caspase-3, the amount of full-
length Ring1B was decreased and a proteolytic 18 kDa protein
product appeared. These data suggest that Ring1B can indeed be
cleaved by caspase-3. To identify the caspase-3 cleavage site,
Ring1BD172A, Ring1BD175A and Ring1BD208A were transfected
and immunoprecipitated. Incubation of Ring1BD172A, and
Ring1BD175A proteins with active caspase-3 showed no
accumulation of cleavage product. However, the Ring1BD208A
mutant protein was cleaved and proteolytic product was similar
to these of wild type proteins generated (Fig. 2D). These data
suggest that DNGD175 is the caspase-3 recognition site and
Asp175 is responsible for caspase-3 cleavage. The single 18 kDa
Fig. 3. Ring1B is cleaved in vivo. (A) Endogenous Ring1B can be cleaved in
vivo. HeLa cells were pre-treated 0, 10, 25 or 50 μM of zVAD for 30 min. 1 μM
of staurosporine was added for 8 h. Cells were collected and lysed with 200 μl
of lysis buffer. Cell lysate was subjected to Western blot and the precursors and
cleaved Ring1B products were detected by using α-Ring1B polyclonal anti-
bodies. α-caspase-9 anti-bodies was used for showing that caspase-9 was
active, α-spectrin and α-β-actin was severing as positive and loading control,
respectively. (B) Overexpressed Ring1B can be cleaved in vivo. HeLa cells
were transfected with 5 μg of flag-Ring1B and 2 μg of GFP for 36 h. Cells were
collected after treating Staurosporine for 0, 2, 4 and 8 h. Ring1B protein was
immunoprecipitated by M2 beads. The immunoprecipitated products were
subjected to Western blot and the precursors and cleaved Ring1B products were
detected by using α-Ring1B polyclonal anti-bodies. Western blot for cell lysate
was carried out. α-caspase-3 and α-caspase-9 anti-bodies were used for
showing that caspase-3 and -9 were active and α-β-actin and α-GFP was used
severing as loading and transfection control, respectively.
Fig. 2. Ring1B was cleaved at aa 175 and aa 208 by active caspase-3 and -9,
respectively in vitro. (A) Ring1B is a direct substrate of caspase-9 in vitro.
[35S]-Methionine labeled Ring1B protein was incubated with increasing amount
of active caspase-9 for 1 h. The reaction mixture was separated by SDS-PAGE
gel. The precursors and cleaved products were visualized by autoradiography.
(B) Caspase-9 cleaves Ring1B specifically at aa 208. [35S]-Methionine labeled
Ring1B protein and its mutant protein were incubated with or without 1 unit of
active caspase-9 for 1 h. The reaction mixture was separated by SDS-PAGE gel.
The precursors and cleaved products were visualized by autoradiography. (C)
Ring 1B is a direct substrate of caspase-3 in vitro. 1 μg of flag-Ring1B was
transfected in 293T cells for 36 h. Ring1B protein was immunoprecipitated by
M2 beads and then was incubated with increasing amount of active caspase-3 for
30 min. The reaction mixture was subjected to Western blot and the precursors
and cleaved products were detected by using α-Ring1B polyclonal anti-bodies.
(D) Caspase-3 cleaves Ring1B specifically at aa 175. 1 μg of Ring1B and its
mutants were expressed in 293T cells. Ring1B and its mutants proteins was
immunoprecipitated by M2 beads and then were incubated with or without 0.5
unit of active caspase-3 for 30 min. The reaction mixture was subjected to
Western blot and the precursors and cleaved products were detected by using
α-Ring1B polyclonal anti-bodies.
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proteolytic fragments of Ring 1B, spanning aa 1–175 (with flag-
tag at N-terminal) and aa 176–336, respectively.3.2. Cleavage of Ring1B protein in vivo after apoptosis
induction
To verify that caspase-dependent Ring1B cleavage can occur
in cells that are trigged to undergo apoptosis. Staurosporine
(STS, 1 μM), a broad-range protein kinase inhibitor, which
induces cell death in many cell types through mitochondria
dependent pathway was introduced into HeLa cells for 8 h.
Active forms of caspase-9 were detected in these cells by using
antibodies that recognize active caspase-9 (Cell Signalling,
USA) (Fig. 3A). Spectrin, a caspase-3 specific substrate was also
cleaved, suggesting the activation of caspase-3 in this process. A
Ring1B proteolytic product, with the size of approximate 18 kDa
848 C.K. Wong et al. / Biochimica et Biophysica Acta 1773 (2007) 844–852that is similar to the Ring1B caspase-3 cleavage product in vitro,
was detected after 8 h of STS treatment (Fig. 3A). Similar
cleavage product was detected in other cell types such as COS-7
cells and 293T cells that are treated with STS (data not shown).
Furthermore, similar Ring1B cleavage product was also detected
in cells induced to undergo apoptosis by other apoptotic stimuli
such as Ultraviolet radiation (UV), etoposide and hydrogenFig. 4. Ring1B Asp175 and Asp208 are cleaved by caspase-3 and caspase-9, respectiv
able to block the cleavage in vivo. HeLa cells were transfected with 5 μg of flag-Ri
incubated with either 50 μM of z-VAD, z-DEVD or z-LEHD for 30 min and we
immunoprecipitated by M2 beads. The immunoprecipitated products and cell lysate
Overexpressed Ring1B double mutant, D175, 208A, cannot be the cleaved in vivo. H
GFP for 36 h. Cells were treated with 1 μM staurosporine or DMSO for another 8 h.
products were subjected to Western blot and the precursors and cleaved Ring1B prod
cell lysate was carried out. α-caspase-3 and α-caspase-9 anti-bodies were used for
severing as loading and transfection control, respectively.peroxide (H2O2) (data not shown). In the presence of increasing
amount of pan-caspase inhibitor z-VAD-fmk, the amount of
Ring1B cleavage product was decreased (Fig. 3A). Ring1B
cleavage product completely disappeared when cells were pre-
incubated with 50 μM z-VAD. There are several possibilities to
explain our observation that in vivo cleavage products of
Ring1B are similar to predicted caspase-3 cleavage product.ely in vivo. (A) Caspase inhibitors and dominant negative form of caspase-9 are
ng1B, 2 μg of GFP and 3 μg of CMV5 or flag-caspase-9C287A. Cells were pre-
re treated with staurosporine or DMSO for another 8 h. Ring1B protein was
were subjected to Western blot by using the anti-bodies same as Fig. 3B. (B)
eLa cells were transfected with 5 μg of flag-Ring1B and its mutants and 2 μg of
Ring1B protein was immunoprecipitated by M2 beads. The immunoprecipitated
ucts were detected by using α-Ring1B polyclonal anti-bodies. Western blot for
showing that caspase-3 and -9 were active and α-β-actin and α-GFP was used
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terminal domain of Ring1B. Second, in the presence of active
caspase-9 and caspase-3, full-length Ring1B was cleaved into
fragments spanning aa 1–175, aa 176–208 and 209–336.
Truncated Ring1B proteins containing aa 1–175 and 209–336
have similar molecular weight and cannot be separated on SDS-
gel. As Ring1B antibody was able to recognize both N-terminal
and C-terminal domains of Ring1B (data not shown), we favour
the second possibility. Regardless, our data suggest that Ring1B
cleavage during apoptosis is dependent on caspase activation in
vivo.
Due to the low abundance of endogenous Ring1B protein we
further confirmed our in vitro observation by expressing flag-
tagged Ring1B in HeLa cells. 1 μM of STS was added and cells
were collected after 0, 2, 4 and 8 h induction. The flag-tagged
Ring1B protein was immunoprecipitated by M2 beads and
followed byWestern blot. The tagged-Ring1B precursor protein
and tagged-Ring1B cleaved product were detected by anti-
Ring1B anti-body. As Fig. 3B shown, when the STS incubation
time increase, the amount of proteolytic Ring1B product at
around 18 kDa and active form of caspase-3 and -9 were
increased. Since we precipitated the tagged Ring1B, solely
N-terminal tagged Ring1B cleaved product and precursor can
be detected. As a result, the cleaved product may represent the
aa 1–175 fragment of Ring1B.
The caspase dependent cleavage of Ring1B was further
confirmed by pre-incubation of the transfected cells with 50 μM
of either pan caspase inhibitor z-VAD, caspase-9 inhibitorFig. 5. Change of Ring1B localization upon cleavage. (A) Schematic representation
localization. (B) Localization of Ring1B and its corresponding cleaved products. GF
cleavage were expressed in COS-7 cells. Cells were fixed with 4% paraformalde
Propedium Iodide (PI) and images were taken under confocal microscope with 60Xz-LEHD or caspase-3 inhibitor z-DEVD for 30 min before STS
treatment. In the presence of pan caspase inhibitor z-VAD,
Ring1B cleavage was blocked (Fig. 4A, lanes 3–4), consistent
with our finding for endogenous Ring1B (Fig. 3A). In the
presence of caspase-9 inhibitor z-LEHD, both caspase-9 and
caspase-3 activity were inhibited as caspase-9 acts upstream of
caspase-3. Consequently, Ring1B cleavage was also blocked
(Fig. 4A, lanes 7–8). When caspase-3 inhibitor z-DEVD was
used, caspase-3 activity was blocked but caspase-9 was still
activated. A larger Ring1B's proteolytic product with mole-
cular weight of approximately 22 kDa corresponding to the
caspase-9 cleavage product aa 1–208 was detected (Fig. 4A,
lanes 1–2 and 5–6). Dominant negative form of caspase-9
(Caspase-9C287A) serves the same role as caspase-9 inhibitor.
As expected, cleavage of Ring1B was blocked with no
proteolytic product observed (Fig. 4A, lanes 9–10). The
appearance of cleaved caspase-3 and caspase-9 products in
the lysate (Fig. 4A, last lane) was likely due to the initiation of
the apoptosis in non-transfected cells induced by STS. Our data
clearly demonstrate that Ring1B can be cleaved during apop-
tosis induction and its cleavage is dependent on both caspase-9
and caspase-3 activity.
To confirm caspase-3 and caspase-9 cleavage sites of Ring1B
in vivo, flag-tagged Ring1B, Ring1BD175A, Ring1BD208A and
Ring1BD175, 208A were transfected into HeLa cells and same
experiment was performed as described in Fig. 3B. As shown in
Fig. 4B, in the presence of STS, both caspase-3 and -9 were
activated. However, the cleavage product of Ring1B mutant,showing the mutants correspond to caspase-3 and -9 cleavages and their nuclear
P vector, GFP-tagged Ring1B and its fragments that corresponding to caspases
hyde and permeabilized with 0.1% Triton X-100. Nuclear were stained with
magnification.
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Ring1B protein (Fig. 4B, lanes 1–4) and similar to the size of
caspase-9 only cleavage product (aa 1–208). Mutation at
Asp208 (Ring1BD208A) yielded a proteolytic product similar to
that of wild-type Ring1B protein (Fig. 4B, lanes 1–2 and 5–6),
corresponding to fragment of aa 1–175. Mutations at both
Asp175 and Asp208 residues (Ring1BD175, 208A) of Ring1B did
not generate any cleavage product after STS induction (Fig. 4B
lanes 7–8). These data are consistent with our in vitro
experiments and suggest that Asp175 and Asp208 are indeed
the caspase-3 and caspase-9 in vivo cleavage sites, respectively.
3.3. Nuclear localization signal of Ring1B
As a component of PcG complex, Ring1B proteins have
been shown to be localized in the nucleus [20]. To examine the
effect of caspase cleavage on Ring1B subcellular localization, a
series of truncated GFP-Ring1B fusion proteins correspond to
caspase-3 or caspase-9 cleavage products (Fig. 5A) were
generated and over-expressed in COS-7 cells. Their sub-cellular
localization was then examined by confocal microscopy. As
expected, GFP-tagged full-length Ring1B protein was localized
in the nucleus (Fig. 5B). Truncated GFP-Ring1B fusion proteins
corresponding to caspase-3 cleavage products, Ring1B1–175 and
Ring 1B176–336, were localized in the cytoplasm and nucleus,
respectively. Similarly, truncated Ring1B proteins correspond-Fig. 6. Loss of Ring1B transcriptional repression activity after caspase cleavage
transcriptional repression activity of Ring1Bis abolished after cleavage. 0.5 μg of GA
expressed in HeLa cells. Luciferase activity was measured at 36 h post-transfection. F
were repeated five times and standard deviation for each experiment was calculated.
mutants were expressed in HeLa cells. Cells were collected and cell lysate was subjeing to caspase-9 cleavage products, Ring1B1–208 and
Ring1B209–336, were localized to the nucleus and cytoplasm,
respectively (Fig. 5B). The specific localization of these fusion
proteins are not due to the variation of their expression levels as
all the GFP proteins were expressed at similar levels (data not
shown). The sub-cellular localization of GFP-tagged Ring1B is
similar to that of non-tagged Ring1B protein (data not shown).
These data suggest that the region responsible for Ring1B
nuclear localization resides between aa 175 and 208, and that
cleavage of Ring1B by caspase-3 and caspase-9 results in the
loss of nuclear localization signals and redistribution of Ring1B
throughout the entire cells.
3.4. Loss of Ring1B transcriptional repression activity after
caspase cleavage
Next, we addressed the functional relationship between
caspases and Ring1B. We first tested whether Ring1B possesses
transcriptional repression activity, as does Ring1A. Full-length
Ring1B and truncated Ring1B mutants, Ring1B91–336,
Ring1B1–175, Ring1B176–336, Ring1B1–208 and Ring1B209–336,
were separately fused to GAL4 DNA binding domain (Fig. 6A).
Their expression levels were evaluated by anti-Ring1B anti-
bodies and showed to be similar (Fig. 6C). As expected, when
fused to GAL4 DNA binding domain, full-length Ring1B was
able to suppress the transcriptional activity of GAL4-TK. (A) Schematic representation for GAL4-Ring1B and its mutants. (B) The
L4-TK reporter construct and 3 μg of GAL4-Ring1B and its mutants were co-
old repression was calculated by comparing with reporter construct. Experiments
(C) Expression of GAL4-Ring1B and its mutants. 3 μg of GAL4-Ring1B and its
cted to Western blot and Ring1B proteins were detected by α-Ring1B anti-body.
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corresponding to caspase-3 and caspase-9 cleavage products
(Ring1B1–175, Ring1B176–336, Ring1B1–208 and Ring1B209–336)
did not exhibit transcriptional repression activity. However,
truncated Ring1B protein lacks of RING domain, Ring1B91–336,
exhibited strong transcriptional repression activity (Fig. 6B).
These data suggest that an intact C-terminal region is important
for Ring1B to act as a transcriptional repressor. The RING
domain is dispensable for such activity. Clearly, cleavage of
Ring1B by caspase-3 or caspase-9 can lead to a disruption of
Ring1B transcriptional repression activity.
4. Discussion
We report here that Ring1B is a direct substrate of active
caspase-3 and caspase-9 both in vitro and in vivo. The sub-
cellular localizations of caspase-cleaved Ring1B proteins were
changed from exclusive nuclear localization to an even
distribution throughout the entire cell. Furthermore, we found
that Ring1B transcriptional repressor activity is dependent on
an intact C-terminal region that can be cleaved by caspase-3
and -9, which results in a loss of its transcriptional repression
activity.
Ring1B has been demonstrated here to be a novel substrate
of caspase-3 and caspase-9. This conclusion is supported by the
following observations. First of all, Ring1B can be cleaved by
active caspase-3 and caspase-9 in vitro, but not by other
caspases. The cleavage sites on Ring1B for caspase-3 and
caspase-9 were mapped to Asp175 and Asp208, respectively, as a
single amino acid substitution of the Asp residues to Ala
completely abrogated caspase-3 or caspase-9 cleavage. Further-
more, we demonstrated clearly that Ring1B can be cleaved in
vivo in response to different apoptotic stimuli such as STS, UV
and H2O2 and cleavage of Ring1B in vivo is dependent on
caspase-3 and caspase-9. The size of cleaved product was
changed when caspase-3 cleavage site of Ring1B was mutated
(Ring1BD175A) or in the presence of caspase-3 inhibitor (z-
DEVD). The cleavage was blocked in the presence of caspase-9
inhibitor (z-LEHD) and dominant negative form of caspase-9
(Caspase-9C287A). In addition, STS induced Ring1B cleavage
was totally abolished when both caspase-3 and -9 cleavage sites
of Ring1B were mutated (Ring1BD175, 208A). Therefore,
Ring1B is a novel substrate of caspase-3 and caspase-9.
However, over-expression of non-cleavable Ring1B proteins
did not affect caspase-9 dependent apoptosis (data not shown).
The pro-caspases are found in different intracellular
compartments, including mitochondria, endoplasmic reticulum,
Golgi apparatus, cytosol and nucleus. The pro-enzyme
subcellular localization is often different from the environment
of action of the activated caspase. Several activated caspases are
translocated to other intracellular compartments, such as the
nucleus, where specific target proteins are cleaved. Although
caspases do not contain a nuclear localization signal, many of
these enzymes are translocated into the nuclei of apoptotic cells
[34]. Numerous nuclear-located proteins, such as PARP, are
cleaved by different caspases, suggesting that caspase translo-
cation into the nucleus is an important event during apoptosis[35]. Since Ring1B is a nuclear protein, upon apoptosis, active
caspase-3 and caspase-9 move from cytoplasm to nucleus to
cleave Ring1B. The cleaved Ring1B fragments, Ring1B1–175
and Ring1B209–336, are no longer resided in nucleus as they do
not contain any nuclear localization signal (Ring1B176–336).
However, the transcriptional repression activity of Ring1B not
only requires the nuclear localization signal but also the intact
C-terminal of Ring1B.
Ring1B is one of the components of PcG protein complex
responsible for transcriptional repression and gene silencing
during development. It was shown to be an E3 ubiquitin ligase
responsible for histone H2A ubiquitination and X-chromosome
inactivation [29,31]. Ring1B full-length protein localizes in the
nucleus and acts as a transcriptional repressor. Here, we mapped
the region responsible for Ring1B nuclear localization resides
between aa 175 and 208. This region contains several basic
amino acid residues that share sequence homology with
canonical nuclear localization signals. Therefore, cleavage of
Ring1B by caspases-3 and -9 during apoptosis generates
proteolytic products without specific nuclear localization signal
and resulting in protein even distribution within the entire cells.
The exact mechanism by which Ring1B acts as a transcriptional
repressor remains elusive. Interestingly, we observed that the
entire region carboxyl to the RING domain is crucial for
Ring1B to act as a transcriptional repressor, indicating that the
transcriptional repressor activity of Ring1B requires a distinct
region from that of Ring1B as an E3 ligase. The target genes of
Ring1B suppression may be different from histone H2A. A
single cleavage by either caspase-3 or caspase-9 will disrupt the
integrity of the C-terminal region of Ring1B and destroy its
transcriptional repressor activity. Overall, our data uncover a
novel role of caspase-3 and -9 in regulating polycomb group
protein function. Upon apoptosis induction and caspase
activation, Ring1B is cleaved by both caspase-3 and caspase-
9, which leads to its protein redistribution and loss of
transcriptional repression. Derepression of Ring1B-regulated
genes may be needed for initiation/execution of apoptosis.
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